TG Therapeutics Investigational Trial Site

Clearwater, Florida 33761

2 studies enrolling now · 2 studies all time

What they study most

Multiple Sclerosis, Myasthenia Gravis, Relapsing Multiple Sclerosis

Studies at this site

• A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS) — Recruiting now
• A Study to Evaluate the Efficacy and Safety of Maintenance Ublituximab Following Induction With Efgartigimod Administration in Participants With Myasthenia Gravis (MG) — Recruiting now